Skip to main content

Zoonotic Virus Spillover Set to Continue Increasing Worldwide

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 3, 2023.

By Elana Gotkine HealthDay Reporter

FRIDAY, Nov. 3, 2023 -- The number of zoonotic spillover events and reported deaths increased by 4.98 and 8.7 percent, respectively, annually, according to a study published online Nov. 2 in BMJ Global Health.

Amanda Jean Meadows, Ph.D., from Ginkgo Bioworks in Emeryville, California, and colleagues used an extensive epidemiological database to analyze a specific subset of high-consequence zoonotic spillover events to assess the annual frequency and severity of outbreaks. The analysis included a subset of pathogens (severe acute respiratory syndrome coronavirus 1, filoviruses, Machupo virus, and Nipah virus) and excluded the severe acute respiratory syndrome coronavirus 2 pandemic.

From 1963 to 2019, there were 75 spillover events in 24 countries, causing 17,232 deaths. The researchers observed a 4.98 and 8.7 percent annual increase in the number of spillover events and reported deaths, respectively, estimated using fitted negative binomial models.

"If the trend we observe in this study continues, we would expect to see these pathogens cause four times the number of spillover events and 12 times the number of deaths in 2050, compared with 2020," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

USDA Testing Beef for H5N1 Amid Current Outbreak in Dairy Cows

TUESDAY, April 30, 2024 -- On Monday, the U.S. Department of Agriculture announced that it is now testing ground beef for any presence of the H5N1 virus that continues to spread...

COVID-19 Viral Load Rebound Can Occur After VV116, Nirmatrelvir-Ritonavir

WEDNESDAY, March 20, 2024 -- For patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116...

2023 to 2024 Seasonal Influenza Vaccine Effective for Reducing Risk

THURSDAY, Feb. 29, 2024 -- The 2023 to 2024 seasonal influenza vaccine is effective for reducing the risk for medically attended influenza virus infection, according to research...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.